Investigating HIV-Human Interaction Networks to Unravel Pathogenic Mechanism for Drug Discovery: A Systems Biology Approach
-
Published:2018-04-19
Issue:1
Volume:16
Page:77-95
-
ISSN:1570-162X
-
Container-title:Current HIV Research
-
language:en
-
Short-container-title:CHR
Author:
Li Cheng-Wei1, Chen Bor-Sen1
Affiliation:
1. Laboratory of Control and Systems Biology, Department of Electrical Engineering, National Tsing Hua University, Hsinchu, Taiwan
Abstract
Background: Two big issues in the study of pathogens are determining how pathogens infect hosts and how the host defends itself against infection. Therefore, investigating host-pathogen interactions is important for understanding pathogenicity and host defensive mechanisms and treating infections.Methods: In this study, we used omics data, including time-course data from high-throughput sequencing, real-time polymerase chain reaction, and human microRNA (miRNA) and protein-protein interaction to construct an interspecies protein-protein and miRNA interaction (PPMI) network of human CD4+ T cells during HIV-1 infection through system modeling and identification.Results: By applying a functional annotation tool to the identified PPMI network at each stage of HIV infection, we found that repressions of three miRNAs, miR-140-5p, miR-320a, and miR-941, are involved in the development of autoimmune disorders, tumor proliferation, and the pathogenesis of T cells at the reverse transcription stage. Repressions of miR-331-3p and miR-320a are involved in HIV-1 replication, replicative spread, anti-apoptosis, cell proliferation, and dysregulation of cell cycle control at the integration/replication stage. Repression of miR-341-5p is involved in carcinogenesis at the late stage of HIV-1 infection.Conclusion: By investigating the common core proteins and changes in specific proteins in the PPMI network between the stages of HIV-1 infection, we obtained pathogenic insights into the functional core modules and identified potential drug combinations for treating patients with HIV-1 infection, including thalidomide, oxaprozin, and metformin, at the reverse transcription stage; quercetin, nifedipine, and fenbendazole, at the integration/replication stage; and staurosporine, quercetin, prednisolone, and flufenamic acid, at the late stage.
Publisher
Bentham Science Publishers Ltd.
Subject
Virology,Infectious Diseases
Reference140 articles.
1. Jansen CA, Piriou E, De Cuyper IM. Antiviral Ther, Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.,, 2006, 11,, 105-116, 2. Perelson AS. Nat Rev Immunol, Modelling viral and immune system dynamics.,, 2002, 2,, 28-36, 3. Duskova K, Nagilla P, Le HS. BMC Infect Dis, MicroRNA regulation and its effects on cellular transcriptome in Human Immunodeficiency Virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts.,, 2013, 2,, 13-, 4. Chen BS, Li CW. BMC Syst Biol, Constructing an integrated genetic and epigenetic cellular network for whole cellular mechanism using high-throughput next-generation sequencing data.,, 2016, 10,, 18-, 5. Sun GH, Li HT, Wu XW. Nucleic Acids Res, Interplay between HIV-1 infection and host microRNAs.,, 2012, 40,, 2181-2196,
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|